Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Paris - Delayed Quote EUR

Safe Orthopaedics SA (ALSAF.PA)

Compare
0.0043
-0.0002
(-4.44%)
At close: April 4 at 5:35:27 PM GMT+2
Loading Chart for ALSAF.PA
  • Previous Close 0.0045
  • Open 0.0045
  • Bid --
  • Ask --
  • Day's Range 0.0038 - 0.0046
  • 52 Week Range 0.0038 - 3.0000
  • Volume 2,619,407
  • Avg. Volume 1,277,643
  • Market Cap (intraday) 122,786
  • Beta (5Y Monthly) 0.61
  • PE Ratio (TTM) --
  • EPS (TTM) -30.0000
  • Earnings Date Apr 28, 2025 - May 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Safe Orthopaedics SA, a medical technology company, engages in the design, manufacturing, and marketing of sterile implants and single-use sterile surgical instruments for the treatment of spinal surgery. The company's products portfolio includes SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies, as well as essential kit for percutaneous treatment of spinal fractures; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. Safe Orthopaedics SA was founded in 2010 and is headquartered in Eragny-sur-Oise, France.

www.safeorthopaedics.com

96

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ALSAF.PA

View More

Performance Overview: ALSAF.PA

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

ALSAF.PA
94.03%
CAC 40 (^FCHI)
1.43%

1-Year Return

ALSAF.PA
99.82%
CAC 40 (^FCHI)
10.75%

3-Year Return

ALSAF.PA
100.00%
CAC 40 (^FCHI)
8.08%

5-Year Return

ALSAF.PA
100.00%
CAC 40 (^FCHI)
75.11%

Compare To: ALSAF.PA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALSAF.PA

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    128.50k

  • Enterprise Value

    199.73M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.00

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    34.38

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -8.19%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.81M

  • Net Income Avi to Common (ttm)

    -205.44M

  • Diluted EPS (ttm)

    -30.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    591k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.72M

Research Analysis: ALSAF.PA

View More

Company Insights: ALSAF.PA

Research Reports: ALSAF.PA

View More

People Also Watch